Fujirebio’s new blood test for Alzheimer’s biomarkers is the first to receive FDA approval, opening the door to Medicare coverage. Here’s what it can…
Should “AD” stand for Alzheimer’s disease, or for Auguste Deter, the patient whose case was first described? Neurologist Donald Weaver explores the history. Auguste…
Common viral infections may make the brain more susceptible to dementia and other neurological diseases. For instance, the Epstein-Barr virus — which causes mononucleosis…
Two scientists at the University of Washington lay out how U.S. cuts to science research funding are expected to have a resounding public health…
What happens when Alzheimer’s — a disease that strikes minority communities the hardest — is largely studied in well-educated whites? Is Alzheimer’s research one-size-fits…